BTAI·09075P204·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
BTAI (BIOXCEL THERAPEUTICS INC) is held by 23 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($2.6M), OAKTREE CAPITAL MANAGEMENT LP ($323,193), GEODE CAPITAL MANAGEMENT, LLC ($308,725). Net institutional sentiment: Mixed.
See how BTAI's score breaks down across 4 SEC sources
Showing 1-20 of 29
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer